Articles

Poll

Podcasts

Slideshows

Videos

Stay updated with the latest healthcare breakthroughs, FDA actions, and new trial data, in this week’s essential news roundup.

The HCPFive: Top News for Healthcare Providers from the Week of 03/01

In February 2026, rusfertide garnered priority review, ASH published new guidelines, and luspatercept mets its primary endpoint in a phase 2a trial.  


5 Hematology Headlines You Missed in February 2026

The FDA granted Priority Review and accepted a New Drug Application for rusfertide to treat adults with polycythemia vera. 


FDA Accepts New Drug Application for Rusfertide, Grants Priority Review In Polycythemia Vera

Panelist member explains new ASH guidelines aim to improve early diagnosis of AL amyloidosis with blood, urine, and biopsy testing.


Key Insights on New ASH Guidelines for AL Amyloidosis, With Joselle Cook, MD

Luspatercept met primary endpoints in transfusion-dependent and non–transfusion-dependent alpha-thalassemia.

Luspatercept Meets Primary Endpoints in Phase 2 Alpha-Thalassemia Trial

In pediatric platelet transfusions, what counts as success depends on the clinical context and treatment goals, not just the platelet count.

Rethinking What Defines Success in Pediatric Platelet Transfusion, With Ruchika Goel, MD

Low post-transfusion platelet increments did not predict mortality or length of stay in pediatric patients.

When Platelet Increments Matter, With Ruchika Goel, MD

Gonzalez explains how new findings in weather-related emergency department visits and pain in pediatric sickle cell disease can guide clinicians. 


Managing Climate Change-Induced Sickle Cell Pain Crises With Frank Gonzalez, MD

The American Society of Hematology released new 2026 Guidelines for Management of Relapsed/Refractory ALL in AYAs, discussing immunotherapy and personalized decision making. 


ASH Releases 8 Recommendations for Relapsed, Refractory Acute Lymphoblastic Leukemia in Adolescents, Young Adults

A retrospective study found an independent association between increased pain episodes in sickle cell disease and the cold in light of increasingly extreme weather.


Extreme Cold Independently Associated with Pain Episodes in Pediatric Sickle Cell Disease

Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria Condition Center page, visitors can find resources on the topics of medical news and expert insight into PNH. Content includes articles, interviews, videos, podcasts, and breaking news on PNH research, treatment, and drug development.

Anemia

Sickle Cell

Sickle Cell condition center page, resources on the topics of medical news and expert insight into sickle cell disease can be found. Content includes articles, interviews, videos, podcasts, and breaking news on sickle cell research, treatment, and drug development.